The Journal of Heart and Lung Transplantation
Volume 29, Issue 3 , Pages 257-260 , March 2010

Role of psychological factors in the clinical course of heart transplant patients

  • Willem J. Kop, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Willem J. Kop, PhD, Department of Medicine, University of Maryland School of Medicine, 22 South Greene Street, S3B08, Baltimore, MD 21201. Telephone: 410-328-2063. Fax: 410-328-4382

References 

  1. Zipfel S, Schneider A, Wild B, et al. Effect of depressive symptoms on survival after heart transplantation. Psychosom Med. 2002;64:740–747
  2. Havik OE, Sivertsen B, Relbo A, et al. Depressive symptoms and all-cause mortality after heart transplantation. Transplantation. 2007;84:97–103
  3. Owen JE, Bonds CL, Wellisch DK. Psychiatric evaluations of heart transplant candidates: predicting post-transplant hospitalizations, rejection episodes, and survival. Psychosomatics. 2006;47:213–222
  4. Dew MA, Kormos RL, Roth LH, et al. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant. 1999;18:549–562
  5. Rutledge T, Reis VA, Linke SE, et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48:1527–1537
  6. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J. 2006;27:2763–2774
  7. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? (A systematic quantitative review). Psychosom Med. 2003;65:201–210
  8. Kop WJ. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom Med. 1999;61:476–487
  9. Rozanski A, Blumenthal JA, Davidson KW, et al. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol. 2005;45:637–651
  10. Lunde DT. Psychiatric complications of heart transplants. Am J Psychiatry. 1969;126:369–373
  11. Zipfel S, Lowe B, Paschke T, et al. Psychological distress in patients awaiting heart transplantation. J Psychosom Res. 1998;45:465–470
  12. Spaderna H, Mendell NR, Zalm D, et al. Social isolation and depression predict 12-month outcomes in the “Waiting for a New Heart Study.”. J Heart Lung Transplant. 2010;29:247–254
  13. Shapiro PA, Williams DL, Foray AT, et al. Psychosocial evaluation and prediction of compliance problems and morbidity after heart transplantation. Transplantation. 1995;60:1462–1466
  14. Cupples S, Dew MA, Grady KL, et al. Report of the Psychosocial Outcomes Workgroup of the Nursing and Social Sciences Council of the International Society for Heart and Lung Transplantation: present status of research on psychosocial outcomes in cardiothoracic transplantation: review and recommendations for the field. J Heart Lung Transplant. 2006;25:716–725
  15. Brandwin M, Trask PC, Schwartz SM, et al. Personality predictors of mortality in cardiac transplant candidates and recipients. J Psychosom Res. 2000;49:141–147
  16. Shah NR, Rogers JG, Ewald GA, et al. Survival of patients removed from the heart transplant waiting list. J Thorac Cardiovasc Surg. 2004;127:1481–1485
  17. Cohen S, Rodriquez MS. Pathways linking affective disturbances and physical disorders. Health Psychol. 1995;14:374–380
  18. Dobbels F, Vanhaecke J, Desmyttere A, et al. Prevalence and correlates of self-reported pretransplant nonadherence with medication in heart, liver, and lung transplant candidates. Transplantation. 2005;79:1588–1595
  19. Salmon P, Stanford SC, Mikhail G, et al. Hemodynamic and emotional responses to a psychological stressor after cardiac transplantation. Psychosom Med. 2001;63:289–299
  20. Lichtman JH, Bigger JT, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118:1768–1775
  21. Martens EJ, Denollet J, Pedersen SS, et al. Relative lack of depressive cognitions in post-myocardial infarction depression. J Affect Disord. 2006;94:231–237
  22. Appels A, Kop WJ, Schouten E. The nature of the depressive symptomatology preceding myocardial infarction. Behav Med. 2000;26:86–89
  23. Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates—2006. J Heart Lung Transplant. 2006;25:1024–1042
  24. Carney RM, Blumenthal JA, Freedland KE, et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med. 2004;66:466–474
  25. Fusar-Poli P, Picchioni M, Martinelli V, et al. Anti-depressive therapies after heart transplantation. J Heart Lung Transplant. 2006;25:785–793
  26. Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design. Psychosom Med. 2001;63:747–755
  27. Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009;87:1497–1504

PII: S1053-2498(09)00846-8

doi: 10.1016/j.healun.2009.10.013

The Journal of Heart and Lung Transplantation
Volume 29, Issue 3 , Pages 257-260 , March 2010

Article Tools

* Image Usage & Resolution